Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 29.05 CNY -5.03% Market Closed
Market Cap: 15.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Interest Income Expense Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Interest Income Expense
-ÂĄ36m
CAGR 3-Years
6%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Interest Income Expense
-ÂĄ3B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
-6%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Interest Income Expense
-ÂĄ719.1m
CAGR 3-Years
-44%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Interest Income Expense
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
-13%
C
China National Medicines Corp Ltd
SSE:600511
Interest Income Expense
ÂĄ534.4m
CAGR 3-Years
30%
CAGR 5-Years
24%
CAGR 10-Years
22%
Huadong Medicine Co Ltd
SZSE:000963
Interest Income Expense
-ÂĄ158.1m
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
-2%

See Also

What is Qingdao Baheal Medical Inc's Interest Income Expense?
Interest Income Expense
-36m CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Interest Income Expense amounts to -36m CNY.

What is Qingdao Baheal Medical Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-7%

Over the last year, the Interest Income Expense growth was 17%. The average annual Interest Income Expense growth rates for Qingdao Baheal Medical Inc have been 6% over the past three years , -7% over the past five years .

Back to Top